News - Pipex Pharmaceuticals Inc.
2008-10-06 09:00:57
Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of autoimmune and central nervous system diseases, announces that it will present at the Maxim Group Growth Conference on Tuesday, October 7, at 9:30 a.m.
Pipex Pharmaceuticals, Inc. To Present at the RedChip Small Cap Investor Conference in New York City
2008-08-19 09:01:13
Pipex Pharmaceuticals, Inc.
